Sonnet Biotherapeutics Correlations

SONN Stock

USD 3.08 0.03 0.98%

The current 90-days correlation between Sonnet Biotherapeutics and ZyVersa Therapeutics is 0.23 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sonnet Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sonnet Biotherapeutics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Sonnet Biotherapeutics Correlation With Market

Significant diversification

The correlation between Sonnet Biotherapeutics Holding and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with Sonnet Stock

0.62	DTIL	Precision BioSciences	Pair Corr
0.67	VINC	Vincerx Pharma	Pair Corr
0.62	EDIT	Editas Medicine	Pair Corr
0.71	EDSA	Edesa Biotech Fiscal Year End 20th of December 2024	Pair Corr

Moving against Sonnet Stock

0.57	VCYT	Veracyte	Pair Corr
0.57	DRUG	Bright Minds Biosciences	Pair Corr
0.54	SABSW	SAB Biotherapeutics	Pair Corr
0.51	VERA	Vera Therapeutics	Pair Corr
0.69	VSTM	Verastem	Pair Corr
0.67	VRNA	Verona Pharma PLC Downward Rally	Pair Corr
0.49	VYGR	Voyager Therapeutics	Pair Corr
0.37	VRTX	Vertex Pharmaceuticals	Pair Corr
0.36	VRDN	Viridian Therapeutics	Pair Corr

Related Correlations Analysis

	YS	ZVSA	ALLR	KRBP	IMMX	CNSP	EFTR	NAVB
YS		0.6	0.68	0.76	0.52	0.55	0.25	0.27	YS
ZVSA	0.6		0.8	0.65	0.61	0.62	0.39	0.68	ZVSA
ALLR	0.68	0.8		0.77	0.88	0.71	0.39	0.82	ALLR
KRBP	0.76	0.65	0.77		0.73	0.58	0.31	0.56	KRBP
IMMX	0.52	0.61	0.88	0.73		0.74	0.18	0.75	IMMX
CNSP	0.55	0.62	0.71	0.58	0.74		0.17	0.52	CNSP
EFTR	0.25	0.39	0.39	0.31	0.18	0.17		0.57	EFTR
NAVB	0.27	0.68	0.82	0.56	0.75	0.52	0.57		NAVB
	YS	ZVSA	ALLR	KRBP	IMMX	CNSP	EFTR	NAVB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Sonnet Stock performing well and Sonnet Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sonnet Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
YS	4.91	(0.73)	(0.53)	10.29	(10.53)	36.81
ZVSA	4.83	(0.67)	0.60	10.28	(10.36)	78.93
ALLR	5.33	(1.55)	(1.19)	13.54	(16.11)	41.48
KRBP	6.00	(0.26)	(0.28)	12.04	(10.96)	65.24
IMMX	3.77	(0.35)	(0.08)	9.38	(8.22)	32.68
CNSP	4.82	(0.28)	(0.05)	17.65	(11.76)	39.29
EFTR	7.57	(4.79)	(2.93)	8.70	(27.78)	88.91
NAVB	6.04	(0.99)	1.40	12.50	(12.50)	40.40

Sonnet Biotherapeutics Corporate Management

Manuel Dafonseca	Head Operations	Profile
Gael Hedou	Chief Officer	Profile
John Cini	Chief CoFounder	Profile
MD FACP	Chief Officer	Profile
Jay Cross	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC